Prescription drug · BLA
Neupogen (Filgrastim) NDC 55513-924
Filgrastim 300 ug/.5mL · Injection, Solution · Intravenous, Subcutaneous · Amgen, Inc
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 55513-924-10 | 5551309241055513092410 | 10 SYRINGE in 1 BOX (55513-924-10) / .5 mL in 1 SYRINGE (55513-924-01)Marketed from Oct 2, 2000 | |
| 55513-924-20 | 5551309242055513092420 | 10 SYRINGE in 1 BOX (55513-924-20) / .5 mL in 1 SYRINGE (55513-924-01)Marketed from Oct 1, 2025 | |
| 55513-924-91 | 5551309249155513092491 | 1 SYRINGE in 1 BOX (55513-924-91) / .5 mL in 1 SYRINGEMarketed from Oct 2, 2000 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Neupogen
- Generic name (nonproprietary)
- filgrastim
- Active ingredients
- Filgrastim — 300 ug/.5mL
- Dosage form
- Injection, Solution
- Route
- Intravenous, Subcutaneous
- Labeler
- Amgen, IncNDC labeler code 55513
- Product type
- Prescription drug
- Marketing category
- BLA — Biologics License ApplicationApplication BLA 103353
- Marketing start
- Listing expires
- Other FDA classes
- Granulocyte Colony-Stimulating Factor (Chemical structure)Increased Myeloid Cell Production (Physiologic effect)
- Identifiers
- Product ID 55513-924_7cedb5f4-cfdd-46a5-836d-e5384c65a224SPL ID 7cedb5f4-cfdd-46a5-836d-e5384c65a224SPL set ID 97cc73cc-b5b7-458a-a933-77b00523e193RxCUI 727535, 727537, 727544, 727545, 1649944, 1649946, 1649963, 1649964UNII PVI5M0M1GWUPC 0355513546102, 0355513530101
- Pharmacologic class
- Leukocyte Growth Factor
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.
- Administration
Drug administration (CPT 96360–96549)
When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.
- NDC on a medical claim
N455513092410followed by a unit qualifier and the quantityPackage 55513-0924-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
NEUPOGEN is a leukocyte growth factor indicated to Decrease the incidence of infection, as manifested by febrile neutropenia, in patients with nonmyeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a significant incidence of severe neutropenia with fever ( 1.1 ) Reduce the time to neutrophil recovery and the duration of fever, following induction or consolidation chemotherapy treatment of patients with acute myeloid leukemia (AML) ( 1.2 ) Reduce the duration of neutropenia and neutropenia-related clinical sequelae, e.g., febrile neutropenia, in patients with nonmyeloid malignancies undergoing myeloablative chemotherapy followed by bone marrow transplantation (BM…
Excerpt only. Read the full label for complete information.
About NDC 55513-924
- What is NDC 55513-924?
- 55513-924 is the product NDC for Neupogen (filgrastim), Filgrastim 300 ug/.5mL injection, solution, listed with the FDA by Amgen, Inc. It has 3 package NDCs, shown above in 10- and 11-digit form.
- What drug is associated with this NDC?
- Neupogen (Filgrastim).
- What is the active ingredient?
- Filgrastim.
- Who is the labeler?
- Amgen, Inc, NDC labeler code 55513. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
- What other NDCs exist for Neupogen?
- 3 other product NDCs are listed under this name. See all Neupogen NDCs.
- Is there a related HCPCS / J-code?
- Not in Med-Code's curated HCPCS directory. See Billing references above.
Related NDCs: other Neupogen products
Other finished products listed under the same name: strengths, forms and labelers.
| Product | Strength | Form · route | Labeler | Product NDC | Package NDCs (11-digit) |
|---|---|---|---|---|---|
| Neupogenfilgrastim | Filgrastim 480 ug/.8mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-209 | 55513-0209-1055513-0209-2055513-0209-91 |
| Neupogenfilgrastim | Filgrastim 300 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-530 | 55513-0530-1055513-0530-20 |
| Neupogenfilgrastim | Filgrastim 480 ug/1.6mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-546 | 55513-0546-1055513-0546-20 |
Other NDCs under BLA 103353
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Neupogenfilgrastim | Filgrastim 480 ug/.8mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-209 |
| Neupogenfilgrastim | Filgrastim 300 ug/mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-530 |
| Neupogenfilgrastim | Filgrastim 480 ug/1.6mL | Injection, SolutionIntravenous, Subcutaneous | Amgen, Inc | 55513-546 |